• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病吸入药物的真实世界应用:优点、缺点与不足

Real-World Use of Inhaled COPD Medications: the Good, the Bad, the Ugly.

作者信息

Press Valerie G.

机构信息

Department of Medicine, University of Chicago, Chicago, Illinois, United States

出版信息

Chronic Obstr Pulm Dis. 2024 Jul 25;11(4):331-340. doi: 10.15326/jcopdf.2024.0546.

DOI:10.15326/jcopdf.2024.0546
PMID:39054287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11363969/
Abstract

Patients with chronic obstructive pulmonary disease (COPD) rely primarily on inhaled medications to control and treat symptoms. Although the medications delivered by inhaler devices are often quite efficacious when delivered to the lung, the real-world effectiveness of these inhaler devices often falls short. Barriers to effective inhaler use include inhaler misuse and cost-related nonadherence. Inhaler misuse can be reduced with appropriate education which leads to improved outcomes. Education can be provided in multiple settings by a wide array of clinicians and clinical team members including pharmacists, respiratory therapists, nurses, physicians, advanced practice nurses, physician assistants, and community health workers, among others. However, despite decades of research and existing effective strategies across settings and types of educators, overall not much progress has been made with respect to effective inhaler technique among populations of patients with COPD in nearly half a century. Similarly, cost-related nonadherence is a long-standing and critical barrier to effective control of COPD, with limited improvements, especially until very recently. This perspective reviews the current promising directions for inhaler-based therapies, ongoing challenges, and critical issues requiring urgent attention.

摘要

慢性阻塞性肺疾病(COPD)患者主要依靠吸入药物来控制和治疗症状。尽管吸入装置输送的药物在输送到肺部时通常相当有效,但这些吸入装置在现实世界中的有效性往往不足。有效使用吸入器的障碍包括吸入器使用不当和与费用相关的不依从性。通过适当的教育可以减少吸入器使用不当的情况,从而改善治疗效果。包括药剂师、呼吸治疗师、护士、医生、高级执业护士、医师助理和社区卫生工作者等在内的众多临床医生和临床团队成员可以在多种环境中提供教育。然而,尽管经过了数十年的研究,并且在不同环境和教育者类型中存在现有的有效策略,但在近半个世纪里,COPD患者群体在有效吸入技术方面总体进展甚微。同样,与费用相关的不依从性是有效控制COPD的一个长期且关键的障碍,改善有限,尤其是直到最近。本观点综述了基于吸入器疗法当前有前景的方向、持续存在的挑战以及需要紧急关注的关键问题。

相似文献

1
Real-World Use of Inhaled COPD Medications: the Good, the Bad, the Ugly.慢性阻塞性肺疾病吸入药物的真实世界应用:优点、缺点与不足
Chronic Obstr Pulm Dis. 2024 Jul 25;11(4):331-340. doi: 10.15326/jcopdf.2024.0546.
2
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
3
Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes.布地奈德/福莫特罗易纳器对哮喘或慢性阻塞性肺疾病患者从既往治疗转换过来后的有效性及患者满意度:一项患者报告结局的真实世界研究
Pulm Ther. 2019 Dec;5(2):165-177. doi: 10.1007/s41030-019-0097-7. Epub 2019 Jul 29.
4
Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.在初级保健环境中管理慢性阻塞性肺疾病中吸入器使用的实用方面。
Int J Chron Obstruct Pulmon Dis. 2012;7:495-502. doi: 10.2147/COPD.S32674. Epub 2012 Jul 25.
5
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病(COPD)药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
6
Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients.吸入药物依从性欠佳和使用技巧不正确在慢性阻塞性肺疾病患者中很常见。
Chron Respir Dis. 2016 Feb;13(1):13-22. doi: 10.1177/1479972315606313. Epub 2015 Sep 22.
7
Long-acting muscarinic antagonist and long-acting β-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review.长效毒蕈碱拮抗剂和长效β-激动剂联合治疗慢性阻塞性肺疾病维持治疗初治患者:叙事性综述。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241279115. doi: 10.1177/17534666241279115.
8
The Importance of Inhaler Adherence to Prevent COPD Exacerbations.吸入器依从性对预防慢性阻塞性肺疾病急性加重的重要性。
Med Sci (Basel). 2019 Apr 1;7(4):54. doi: 10.3390/medsci7040054.
9
Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.慢性阻塞性肺疾病患者正确使用吸入器的相关因素——来自真实调查的经验教训
Int J Chron Obstruct Pulmon Dis. 2018 Feb 26;13:695-702. doi: 10.2147/COPD.S149404. eCollection 2018.
10
The Role of the Pharmacist in Inhaler Selection and Education in Chronic Obstructive Pulmonary Disease.药剂师在慢性阻塞性肺疾病吸入器选择与教育中的作用
J Pharm Technol. 2021 Apr;37(2):95-106. doi: 10.1177/8755122520937649. Epub 2020 Jul 8.

引用本文的文献

1
Community Pharmacy Service for Patients With Inhaled Medications: A Multi-Perspective Observation and Assessment Under Routine Conditions.吸入药物患者的社区药房服务:常规条件下的多视角观察与评估
J Eval Clin Pract. 2025 Sep;31(6):e70271. doi: 10.1111/jep.70271.

本文引用的文献

1
Digital Redlining-The Invisible Structural Determinant of Health.数字红线——健康的无形结构决定因素。
JAMA. 2024 Apr 16;331(15):1267-1268. doi: 10.1001/jama.2024.1628.
2
Accessibility of Pulmonary Rehabilitation in the US.美国肺康复的可及性
JAMA Netw Open. 2024 Feb 5;7(2):e2354867. doi: 10.1001/jamanetworkopen.2023.54867.
3
Inhaler Formulary Change in COPD and the Association with Exacerbations, Health Care Utilization, and Costs.慢性阻塞性肺疾病吸入器处方集的变化及其与急性加重、医疗保健利用和成本的关联。
Chronic Obstr Pulm Dis. 2024 Jan 25;11(1):37-46. doi: 10.15326/jcopdf.2023.0425.
4
The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD.《2023年慢性阻塞性肺疾病全球倡议报告:稳定期慢性阻塞性肺疾病患者吸入药物治疗更新指南》
Pulm Ther. 2023 Sep;9(3):345-357. doi: 10.1007/s41030-023-00233-z. Epub 2023 Jul 20.
5
Insufficient Patient Access to Pulmonary Rehabilitation: A Multifaceted Problem.患者获得肺康复治疗的机会不足:一个多方面的问题。
Ann Am Thorac Soc. 2023 Apr;20(4):510-512. doi: 10.1513/AnnalsATS.202301-032ED.
6
Evaluating inhaler education interventions for hospitalized children with asthma: A randomized controlled trial.评估哮喘住院患儿吸入器教育干预措施的随机对照试验。
Ann Allergy Asthma Immunol. 2023 Aug;131(2):217-223.e1. doi: 10.1016/j.anai.2023.02.023. Epub 2023 Mar 3.
7
Patenting Strategies on Inhaler Delivery Devices.吸入器给药装置的专利策略。
Chest. 2023 Aug;164(2):450-460. doi: 10.1016/j.chest.2023.02.031. Epub 2023 Feb 25.
8
The Relation Between eHealth Literacy and Health-Related Behaviors: Systematic Review and Meta-analysis.电子健康素养与健康相关行为的关系:系统评价和荟萃分析。
J Med Internet Res. 2023 Jan 30;25:e40778. doi: 10.2196/40778.
9
Manufacturer Revenue on Inhalers After Expiration of Primary Patents, 2000-2021.2000 - 2021年主要专利到期后吸入器的制造商收入
JAMA. 2023 Jan 3;329(1):87-89. doi: 10.1001/jama.2022.19691.
10
Inequities in Technology Contribute to Disparities in COVID-19 Vaccine Distribution.技术不平等导致了新冠疫苗分配的差异。
JAMA Health Forum. 2021 Mar 1;2(3):e210264. doi: 10.1001/jamahealthforum.2021.0264.